Accedi

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.

Ras is a superfamily of small GTPase proteins that facilitate the transmission of signals by continually cycling between an active GTP-bound form and an inactive GDP-bound form, thereby acting as molecular switches. The exchange of GDP with GTP, facilitated by the guanine nucleotide exchange factors or GEFs, turns ‘on’ the Ras proteins. The GTPase-activating proteins or GAPs catalyze the hydrolysis of GTP to GDP, turning ‘off’ the Ras proteins. An active Ras-GTP binds and activates its downstream effector molecules involved in cell growth and proliferation signaling.

Some specific point mutations, such as in codons 12, 13, or 61 in the Ras genes, result in the production of significantly impaired proteins. These mutations can affect the overall GTPase activity in the Ras proteins or impair the GAP sensitivity of the proteins. The absence of GTP hydrolysis locks the proteins into a constitutively active state. The mutant Ras proteins continually transmit signals to downstream effector molecules in the pathway, even in the absence of external stimuli, triggering the uncontrolled proliferation of cells.

Ras mutations can be found in up to 30 percent of all the human tumors screened, most commonly in colorectal carcinoma, non-small cell lung carcinoma, and pancreatic ductal adenocarcinoma. Mutations in K-ras locus are found in about 25-30 percent of tumor samples, N-ras mutations in about 8 percent of tumors, and H-ras mutations in only about 3 percent of tumors.

Tags
Ras GeneRas ProteinsGTPaseCell ProliferationCell DifferentiationCell SurvivalCancerMutationsTumorColorectal CarcinomaLung CarcinomaPancreatic AdenocarcinomaGTPGDPGEFsGAPsEffector MoleculesSignaling Pathways

Dal capitolo 20:

article

Now Playing

20.9 : The Ras Gene

Cancer

6.0K Visualizzazioni

article

20.1 : Cosa sono i tumori?

Cancer

9.8K Visualizzazioni

article

20.2 : I tumori hanno origine da mutazioni somatiche in una singola cellula

Cancer

11.1K Visualizzazioni

article

20.3 : Progressione del tumore

Cancer

5.9K Visualizzazioni

article

20.4 : Meccanismi adattativi nelle cellule tumorali

Cancer

5.4K Visualizzazioni

article

20.5 : Il microambiente tumorale

Cancer

6.2K Visualizzazioni

article

20.6 : Metastasi

Cancer

5.3K Visualizzazioni

article

20.7 : Carcinogenesi I: proto-oncogeni

Cancer

8.2K Visualizzazioni

article

20.8 : Meccanismi dei tumori indotti da retrovirus

Cancer

4.8K Visualizzazioni

article

20.10 : Perdita di funzione dei geni oncosoppressori

Cancer

4.5K Visualizzazioni

article

20.11 : Via di segnalazione di mTOR e progressione del tumore

Cancer

3.6K Visualizzazioni

article

20.12 : Cellule staminali cancerose e mantenimento del tumore

Cancer

4.5K Visualizzazioni

article

20.13 : Modelli murini per lo studio del tumore

Cancer

5.4K Visualizzazioni

article

20.14 : Prevenzione del cancro

Cancer

5.9K Visualizzazioni

article

20.15 : Terapie tumorali

Cancer

7.1K Visualizzazioni

See More

JoVE Logo

Riservatezza

Condizioni di utilizzo

Politiche

Ricerca

Didattica

CHI SIAMO

Copyright © 2025 MyJoVE Corporation. Tutti i diritti riservati